Most a short while ago, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar spots as classical opioid receptors, it binds to the big range of endogenous opioids. Unlike most opioid receptors, this receptor acts for a scavenger and does not activate a